residual antimalarials in malaria patients from tanzania – implications on drug efficacy assessment and spread of parasite resistance剩余抗疟疾病人从坦桑尼亚u2014u2014影响药物疗效评估和传播疟疾寄生虫对青蒿素的耐药性.pdfVIP

residual antimalarials in malaria patients from tanzania – implications on drug efficacy assessment and spread of parasite resistance剩余抗疟疾病人从坦桑尼亚u2014u2014影响药物疗效评估和传播疟疾寄生虫对青蒿素的耐药性.pdf

  1. 1、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
  2. 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  3. 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
  4. 4、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
  5. 5、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们
  6. 6、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
  7. 7、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
residual antimalarials in malaria patients from tanzania – implications on drug efficacy assessment and spread of parasite resistance剩余抗疟疾病人从坦桑尼亚u2014u2014影响药物疗效评估和传播疟疾寄生虫对青蒿素的耐药性

Residual Antimalarials in Malaria Patients from Tanzania – Implications on Drug Efficacy Assessment and Spread of Parasite Resistance 1 2 2 3 3 Eva Maria Hodel , Abdunoor Mulokozi Kabanywanyi , Aggrey Malila , Boris Zanolari , Thomas Mercier , 1 3 4 3 1,5 Hans-Peter Beck , Thierry Buclin , Piero Olliaro , Laurent Arthur Decosterd , Blaise Genton * 1 Swiss Tropical Institute, Basel, Switzerland, 2 Ifakara Health Institute, Dar es Salaam and Ifakara, Tanzania, 3 Division of Clinical Pharmacology, Department de Medicine, University Hospital and University of Lausanne, Lausanne, Switzerland, 4 UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (TDR), Geneva, Switzerland, 5 Department of Ambulatory Care and Community Medicine, University of Lausanne, Lausanne, Switzerland Abstract Background: Repeated antimalarial treatment for febrile episodes and self-treatment are common in malaria-endemic areas. The intake of antimalarials prior to participating in an in vivo study may alter treatment outcome and affect the interpretation of both efficacy and safety outcomes. We report the findings from baseline plasma sampling of malaria patients prior to inclusion into an in vivo study in Tanzania and discuss the implications of residual concentrations of antimalarials in this setting. Methods and Findings: In an in vivo study conducted in a rural area of Tanzania in 2008, baseline plasma samples from patients reporting no antimalarial intake with

您可能关注的文档

文档评论(0)

xyz118 + 关注
实名认证
文档贡献者

该用户很懒,什么也没介绍

1亿VIP精品文档

相关文档